[1. Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances [displayed 10 May 2018]. Available at https://publications.europa.eu/en/publication-detail/-/publication/1220f240-3f1a-4a14-9df7-9cd2b297f4bb/language-en]Search in Google Scholar
[2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Understanding the ‘Spice’ Phenomenon. Thematic papers. Lisbon: EMCDDA; 2009.]Search in Google Scholar
[3. Gurney SM, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev 2014;26:53-78. PMID: 26226970]Search in Google Scholar
[4. Hurst D, Loeffler G, McLay R. Psychosis associated with synthetic cannabinoid agonists: a case series. Am J Psychiatry 2011;168:1119. doi: 10.1176/appi.ajp.2011.1101017610.1176/appi.ajp.2011.1101017621969050]Open DOISearch in Google Scholar
[5. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Perspectives on Drugs. Synthetic cannabinoids in Europe [displayed 4 May 2018]. Available at http://www.emcdda.europa.eu/system/files/publications/2753/POD_Synthetic%20cannabinoids_0.pdf]Search in Google Scholar
[6. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Synthetic cannabinoids and “Spice” drug profile [displayed 4 May 2018]. Available at https://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cannabinoids]Search in Google Scholar
[7. Namera A, Kawamura M, Nakamoto A, Saito T, Nagao M. Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. Forensic Toxicol 2015;33:175-94. doi: 10.1007/s11419-015-0270-010.1007/s11419-015-0270-0452520826257831]Open DOISearch in Google Scholar
[8. Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol 2011;49:760-4. doi: 10.3109/15563650.2011.60982210.3109/15563650.2011.609822416560321970775]Search in Google Scholar
[9. Spaderna M, Addy PH, Deepak CDS. Spicing things up: Synthetic cannabinoids. Psychopharmacology (Berl) 2013;228:525-40. doi: 10.1007/s00213-013-3188-410.1007/s00213-013-3188-4379995523836028]Open DOISearch in Google Scholar
[10. Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-18 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One 2011;6(7):e21917. doi: 10.1371/journal.pone.002191710.1371/journal.pone.0021917313077721755008]Search in Google Scholar
[11. Ergül DF, Ekemen S, Yelken BB. Synthetic cannabinoid ´Bonsai´ intoxication: six case series. Turk J Anaestesiol Reanim 2015;43:347-51. doi: 10.5152/TJAR.2015.0566810.5152/TJAR.2015.05668489423727366526]Open DOISearch in Google Scholar
[12. United Nations Office on Drugs and Crime (UNODC). Synthetic cannabinoids in herbal products, 2011 [displayed 4 May 2018]. Available at https://www.unodc.org/unodc/en/scientists/synthetic-cannabinoids-in-herbal-products_new.html]Search in Google Scholar
[13. Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, Impagnatiello M, Pascolo-Fabrici E, Bonavigo T. “Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report. Hum Psychopharmacol Clin Exp 2013;28:379-89. doi: 10.1002/hup.231210.1002/hup.231223881886]Open DOISearch in Google Scholar
[14. American Association of Poison Control Centres. Synthetic Cannabinoids [displayed 4 May 2018]. Available at http://www.aapcc.org/alerts/synthetic-cannabinoids/]Search in Google Scholar
[15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Health responses to new psychoactive substances. Lisbon: EMCDDA; 2016. doi: 10.2810/04241210.2810/042412]Open DOISearch in Google Scholar
[16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). New psychoactive substances in Europe. An update from the EU Early Warning Sytem March 2015. Luxembourg: Publication Office of the European Union; 2015. doi: 10.2810/37241510.2810/372415]Open DOISearch in Google Scholar
[17. Emerson B, Durham B, Gidden J, Lay Jr JO. Gas chromatographymass spectrometry of JWH-018 metabolites in urine samples with direct comparison to analytical standards. Forensic Sci Int 2013;229:1-6. doi: 10.1016/j.forsciint.2013.03.00610.1016/j.forsciint.2013.03.006366096623683902]Open DOISearch in Google Scholar
[18. Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, Kennedy PD, Endres GW, Ciske FL, Kramer JB, Kornilov AM, Bratton LD, Dobrowolski PJ, Wessinger WD, Fantegrossi WE, Prather PP, James LP, Radominska-Pandya A, Moran JH. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem 2011;83:4228-36. doi: 10.1021/ac200563610.1021/ac2005636310546721506519]Open DOISearch in Google Scholar
[19. Hutter M, Broecker S, Kneisel S, Auwärter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterans in “herbal mixtures” using LC-MS/MS techniques. J Mass Spectrom 2012;47:54-6. doi: 10.1002/jms.202610.1002/jms.202622282090]Open DOISearch in Google Scholar
[20. Schneir AB, Baumbacher T. Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol 2012;8:62-4. doi: 10.1007/s13181-011-0182-210.1007/s13181-011-0182-2355022722160733]Search in Google Scholar
[21. Kronstrand R, Roman M, Andersson M, Eklund A. Toxicological findings of synthetic cannabinoids in recreational users. J Anal Toxicol 2013;37:534-41. doi: 10.1093/jat/bkt06810.1093/jat/bkt06823970540]Open DOISearch in Google Scholar
[22. Mdege ND, Meader N, Lloyd C, Parrott S, McCambridge J. The Novel Psychoactive Sunstances in the UK Project: empirical and conceptual review of work to produce research recommendations. Final Report. Public Health Res 2017;5:1-11. doi: 10.3310/phr0504010.3310/phr0504028678463]Open DOISearch in Google Scholar
[23. Busquets Garcia A, Soria-Gomez E, Bellochio L, Marsicano G. Cannabinoid receptor type-1: breaking the dogmas. F1000Res 2016;5. pii: F1000 Faculty Rev-990. doi: 10.12688/f1000research.8245.110.12688/f1000research.8245.1487993227239293]Open DOISearch in Google Scholar